CHF159.60
1.36% today
SIX Swiss Exchange, Jul 01, 09:15 am CET
ISIN
CH0012100191
Symbol
TECN
Sector

Tecan Group Ltd. Stock price

CHF161.80
-1.90 1.16% 1M
-40.80 20.14% 6M
-40.80 20.14% YTD
-140.40 46.46% 1Y
-115.40 41.63% 3Y
-173.80 51.79% 5Y
+49.80 44.46% 10Y
+120.80 294.63% 20Y
SIX Swiss Exchange, Closing price Mon, Jun 30 2025
+0.20 0.12%
ISIN
CH0012100191
Symbol
TECN
Sector

Key metrics

Basic
Market capitalization
CHF2.1b
Enterprise Value
CHF2.0b
Net debt
positive
Cash
CHF406.0m
Shares outstanding
12.7m
Valuation (TTM | estimate)
P/E
30.53 | 23.69
P/S
2.22 | 2.15
EV/Sales
2.13 | 2.07
EV/FCF
16.87
P/B
1.43
Dividends
DPS
CHF3.00
Yield 1Y | 5Y
1.85% | 0.76%
Growth 1Y | 5Y
0.00% | 6.40%
Payout 1Y | 3Y
56.71% | 35.51%
Increased
0 Years
Financials (TTM | estimate)
Revenue
CHF934.3m | CHF961.9m
EBITDA
CHF148.0m | CHF168.6m
EBIT
CHF75.6m
Net Income
CHF67.7m | CHF87.0m
Free Cash Flow
CHF117.9m
Growth (TTM | estimate)
Revenue
-13.04% | 2.95%
EBITDA
-28.62% | 54.65%
EBIT
-44.42%
Net Income
-48.77% | 28.52%
Free Cash Flow
-6.18%
Margin (TTM | estimate)
Gross
34.32%
EBITDA
15.84% | 17.53%
EBIT
8.09%
Net
7.24% | 9.04%
Free Cash Flow
12.62%
Financial Health
Equity Ratio
-
Return on Equity
-
ROCE
4.75%
ROIC
4.33%
Debt/Equity
0.22
More
EPS
CHF5.30
FCF per Share
CHF9.26
Short interest
-
Employees
3.21k
Rev per Employee
CHF290.00k
Show more

Is Tecan Group Ltd. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,948 stocks worldwide.

Tecan Group Ltd. Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Tecan Group Ltd. forecast:

7x Buy
54%
6x Hold
46%

Analyst Opinions

13 Analysts have issued a Tecan Group Ltd. forecast:

Buy
54%
Hold
46%

Financial data from Tecan Group Ltd.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
934 934
13% 13%
100%
- Direct Costs 614 614
10% 10%
66%
321 321
18% 18%
34%
- Selling and Administrative Expenses 183 183
4% 4%
20%
- Research and Development Expense 68 68
2% 2%
7%
148 148
29% 29%
16%
- Depreciation and Amortization 72 72
2% 2%
8%
EBIT (Operating Income) EBIT 76 76
44% 44%
8%
Net Profit 68 68
49% 49%
7%

In millions CHF.

Don't miss a Thing! We will send you all news about Tecan Group Ltd. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Tecan Group AG operates as a holding company. The firm engages in the development, production and distribution of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. It operates through the following segments: Life Sciences Business and Partnering Business. The Life Sciences Business segment supplies end users with automated workflow solutions, which includes laboratory instruments, software packages, application know-how, services, consumables and spare parts. The Partnering Business segment develops and manufactures original equipment manufacturer instruments and components. The company was founded by Heinz Abplanalp, Heini Maurer, Heini Moeckli and Gallus Blatter on March 18, 1980 and is headquartered in Mannedorf, Switzerland.

Head office Switzerland
CEO Achim Leoprechting
Employees 3,208
Founded 1980
Website www.tecan.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today